{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-043590","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.970569+00:00","generated_at":"2026-06-21T11:35:41.354958+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AngioDynamics guides Q2 cash ~$28-30M; results due Jan 5, 2023","bullets":["Expected cash at Nov 30, 2022 (Q2 FY2023 end): $28-30 million.","Net cash increase of ~$3.5-5.5M from Q1 FY2023 end.","Cash guidance excludes $4.2M CARES Act receivable.","Q2 FY2023 earnings scheduled for release on or around Jan 5, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-043590","json":"https://secwatch.observer/filing/0001140361-22-043590.json","markdown":"https://secwatch.observer/filing/0001140361-22-043590.md","text":"https://secwatch.observer/filing/0001140361-22-043590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036122043590/0001140361-22-043590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036122043590/brhc10044862_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:35:41.354958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}